Skip to main content

Advertisement

Table 6 Frequency and prevalence (%) of representatives of HPV grouped by age, nationality and year

From: HPV genotype prevalence and distribution during 2009–2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination

  HPV16 HPV52 HPV53 HPV58
Age
  ≤ 25 78 (4.36%) 59 (3.30%) 32 (1.79) 41 (2.29%)
 26–30 182 (3.70%) 130 (2.64%) 61 (1.24%) 74 (1.50%)
 31–35 227 (3.86%) 136 (2.31%) 65 (1.11%) 114 (1.94%)
 36–40 313 (4.94%) 185 (2.92%) 98 (1.55%) 135 (2.13%)
 41–45 283 (4.02%) 184 (2.61%) 92 (1.31%) 120 (1.70%)
 46–50 178 (3.29%) 124 (2.29%) 81 (1.50%) 93 (1.72%)
 51–55 88 (2.79%) 61 (1.93%) 56 (1.77%) 45 (1.42%)
  ≥ 56 113 (3.56%) 74 (2.33%) 35 (1.10%) 58 (1.83%)
Nation
 Other 17 (3.21%) 19 (3.59%) 2 (0.38%) 15 (2.84%)
 Han 1107 (3.79%) 808 (2.77%) 413 (1.42%) 565 (1.94%)
 Hui 58 (4.26%) 42 (3.09%) 19 (1.40%) 32 (2.35%)
 Kazak 63 (5.77%) 8 (0.73%) 18 (1.65%) 17 (1.56%)
 Mongol 22(4.55%) 14(2.90%) 8(1.66%) 6 (1.24%)
 Uygher 195(3.84%) 62(1.22%) 60(1.18%) 45 (0.89%)
Year
 2009 140 (7.09%) 55 (2.79%) 35 (1.77%) 59 (2.99%)
 2010 191 (8.23%) 76 (3.27%) 80 (3.45%) 84 (3.62%)
 2011 157 (8.04%) 47 (2.41%) 32 (1.64%) 63 (3.22%)
 2012 195 (8.29%) 98 (4.17%) 61 (2.59%) 78 (3.32%)
 2013 167 (9.75%) 106 (6.19%) 71 (4.15%) 88 (5.14%)
 2014 119 (8.02%) 68 (4.59%) 35 (2.36%) 59 (3.98%)
 2015 108 (3.48%) 106 (3.41%) 42 (1.35%) 51 (1.64%)
 2016 145 (2.18%) 221 (3.31%) 87 (1.31%) 64 (0.96%)
 2017 103 (0.96%) 94 (0.88%) 36 (0.34%) 65 (0.61%)
 2018 120 (2.24%) 80 (1.49%) 40 (0.74%) 62 (1.16%)